Alt5 Sigma Corporation
Material Event (Form 8-K)
Item 8.01 Other Events. Commencing in late 2024, ALT5 Sigma Corporation (the "Company") had disclosed a strategic plan to separate into two distinct companies and its intent to finance Alyea Therapeutics Corporation ("Alyea") separately from the Company in a manner that was to be determined. As a result of several factors, a potential spin-off, or similar t ...
